This FDA InspectorProfile is a report of relevant audit-related information on Paul Bellamy, a U.S. Food & Drug Administration investigator who primarily conducts inspections in the area of Human Drugs.
This InspectorProfile report is updated through and lists Paul Bellamy's inspections in 27 countries: United States, Canada, Finland, Netherlands, Germany, United Kingdom, Malta & Gozo, Denmark, Italy, France, Spain, India, China, Japan, Jordan, Israel, Korea (the Republic of), Australia, Singapore, Philippines, Austria, Mexico, Taiwan (Province of China), Taiwan, Poland, Norway, and Portugal.
FDA audits are stressful. Whether you are issued a 483 depends largely on your compliance with GxP and predicate rules; but it can also depend on the Agency's current focus and the tendencies of your specific investigator(s). FDAzilla has curated Paul Bellamy's inspection information so that you can mitigate investigator-related risks.
Below is an example of what a FDAzilla InspectorProfile report contains; This is not the actual data for Paul Bellamy.
Note: The EIR and 483 documents are sold separately.